Michael D. Dale, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 1,347 shares at $88.97 ($120K) on 2020-02-19, disclosed to the SEC on 2020-02-19.
Scheduled sale ($120k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.66 | 951 | $85K | 70.8% |
| 2 | $88.97 | 396 | $35K | 29.2% |
| Total | $89.46 avg | 1,347 | $120K | 100% |
| Filing → |
| ABT | SELL | 2023-03-02 | $243K | — | Filing → |
| ABT | SELL | 2022-03-10 | $468K | — | Filing → |
| ABT | SELL | 2022-03-02 | $249K | — | Filing → |